Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition
Pre-exposure prophylaxis (PrEP) is an important HIV prevention option. Two randomized trials have provided efficacy evidence for long-acting injectable cabotegravir (CAB-LA) as PrEP. In considering CAB-LA as an additional PrEP modality for people at substantial risk of HIV, it is important to understand community response to injectable PrEP. We conducted a systematic review of values, preferences and perceptions of acceptability for injectable PrEP to inform global guidance.
July 2023
Click for full info +Full Info:
Resource Type:
Database
Journal Article
Journal Article
Resource
Citation:
Pre-exposure prophylaxis (PrEP) is an important HIV prevention option. Two randomized trials have provided efficacy evidence for long-acting injectable cabotegravir (CAB-LA) as PrEP. In considering CAB-LA as an additional PrEP modality for people at substantial risk of HIV, it is important to understand community response to injectable PrEP. We conducted a systematic review of values, preferences and perceptions of acceptability for injectable PrEP to inform global guidance.
Authors: Lorenzetti, L., Dinh, N., van der Straten, A., Fonner, V., Ridgeway, K., Rodolph, M., Schaefer, R., Schmidt, H.M.A. and Baggaley, R.
Health Risks(s):
- HIV
Product type(s):
- HIVinhibitor
- Injectables
Topic(s):
- Development
- Social